<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973206</url>
  </required_header>
  <id_info>
    <org_study_id>AUTH20090609</org_study_id>
    <nct_id>NCT00973206</nct_id>
  </id_info>
  <brief_title>Factors Influencing Cardiovascular Prognosis</brief_title>
  <acronym>Pythia-GR</acronym>
  <official_title>Factors Influencing Cardiovascular Prognosis in Hypertensive Patients (Pythia Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aristotle University Of Thessaloniki</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aristotle University Of Thessaloniki</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify risks for cardiovascular events in a follow up&#xD;
      period of 10 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion criteria&#xD;
&#xD;
        -  Age &gt; 50 years volunteers (2 towns of 15000 residents one in the north and one in the&#xD;
           south of Greece)&#xD;
&#xD;
        -  End points&#xD;
&#xD;
        -  5-10 years cardiovascular morbidity and mortality&#xD;
&#xD;
      Measurements at baseline&#xD;
&#xD;
        -  Anthropometrics&#xD;
&#xD;
             -  Age (M&gt;55 years; W&gt;65 years)&#xD;
&#xD;
             -  Weight-height- BMI&#xD;
&#xD;
             -  Abdominal obesity (Waist circumference&gt;102 cm(M), &gt;88cm (W) Family history&#xD;
&#xD;
             -  Family history of premature CV disease (M at age&lt;55 years; W at age&lt;65 years)&#xD;
&#xD;
      History&#xD;
&#xD;
        -  Smoking&#xD;
&#xD;
        -  Diabetes Mellitus,&#xD;
&#xD;
        -  Established Heart disease: myocardial infarction; angina; coronary revascularization;&#xD;
           heart failure&#xD;
&#xD;
        -  Established renal disease [diabetic nephropathy; renal impairment (serum creatinine&#xD;
           M&gt;133, W&gt;124 mmol/l); proteinuria (&gt; 300 mg/24 h)]&#xD;
&#xD;
        -  Cerebrovascular disease: ischaemic stroke; cerebral haemorrhage; transient ischaemic&#xD;
           attack&#xD;
&#xD;
        -  Peripheral artery disease&#xD;
&#xD;
        -  Advanced retinopathy: haemorrhages or exudates, papilloedema&#xD;
&#xD;
        -  Treatment&#xD;
&#xD;
      Measurements&#xD;
&#xD;
        -  Measurements Blood pressure&#xD;
&#xD;
             -  Clinic BP&#xD;
&#xD;
             -  24h ABPM&#xD;
&#xD;
             -  Home BP&#xD;
&#xD;
      Heart&#xD;
&#xD;
        -  Electrocardiographic LVH&#xD;
&#xD;
        -  Echocardiographic LVH&#xD;
&#xD;
      Vessels&#xD;
&#xD;
        -  Carotid wall thickening or plaque&#xD;
&#xD;
        -  Carotid-femoral pulse wave velocity&#xD;
&#xD;
        -  Ankle/brachial BP index&#xD;
&#xD;
      Lipids or other risk factors&#xD;
&#xD;
        -  Total cholesterol, Tg, HDL, LDL&#xD;
&#xD;
        -  Plasma creatinine, estimated glomerular filtration rate&#xD;
&#xD;
        -  Fasting plasma glucose or postload plasma glucose&#xD;
&#xD;
        -  Microalbuminuria and albumin-creatinine ratio&#xD;
&#xD;
        -  Glucose tolerance test&#xD;
&#xD;
             -  Follow up each 3 year with all the above measurements&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2017</start_date>
  <completion_date type="Anticipated">January 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular mortality</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospitalization for CV events</measure>
    <time_frame>10 years</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Cardiovascular Mortality</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Volunteers,community sample, residents of a certain town&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All age &gt;50 volunteers&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vasilios Kotsis, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>AUTH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Vasilios Kotsis, Prof</last_name>
    <phone>6974748860</phone>
    <phone_ext>+30</phone_ext>
    <email>vkotsis@auth.gr</email>
  </overall_contact>
  <verification_date>June 2014</verification_date>
  <study_first_submitted>September 8, 2009</study_first_submitted>
  <study_first_submitted_qc>September 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <last_update_submitted>June 24, 2014</last_update_submitted>
  <last_update_submitted_qc>June 24, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 25, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aristotle University Of Thessaloniki</investigator_affiliation>
    <investigator_full_name>Vasilios Kotsis</investigator_full_name>
    <investigator_title>Prof. Med</investigator_title>
  </responsible_party>
  <keyword>cardiovascular morbidity</keyword>
  <keyword>mortality community study</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

